Age is a major modifier of inflammatory CSF signatures in MS. This finding identifies novel biomarker candidates and potential therapeutic targets.
A groundbreaking study published in BMC Nephrology found that metabolic dysfunction associated fatty liver disease (MAFLD) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback